IDR 2360.0
(-2.07%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 916.13 Billion IDR | -9.11% |
2022 | 1007.99 Billion IDR | -17.97% |
2021 | 1228.82 Billion IDR | 46.0% |
2020 | 841.67 Billion IDR | 15.27% |
2019 | 730.14 Billion IDR | 19.0% |
2018 | 613.55 Billion IDR | -9.75% |
2017 | 679.8 Billion IDR | -2.25% |
2016 | 695.43 Billion IDR | 22.69% |
2015 | 566.82 Billion IDR | 9.64% |
2014 | 516.99 Billion IDR | 29.69% |
2013 | 398.64 Billion IDR | 33.38% |
2012 | 298.87 Billion IDR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q3 | 272.32 Billion IDR | -12.62% |
2024 Q1 | 288.91 Billion IDR | 25.6% |
2024 Q2 | 311.64 Billion IDR | 7.87% |
2023 Q2 | 222.46 Billion IDR | -3.54% |
2023 Q4 | 230.02 Billion IDR | -1.28% |
2023 Q3 | 233 Billion IDR | 4.73% |
2023 FY | 916.13 Billion IDR | -9.11% |
2023 Q1 | 230.63 Billion IDR | -12.58% |
2022 FY | 1007.99 Billion IDR | -17.97% |
2022 Q3 | 214.41 Billion IDR | -17.66% |
2022 Q4 | 263.8 Billion IDR | 23.04% |
2022 Q2 | 260.39 Billion IDR | -3.33% |
2022 Q1 | 269.36 Billion IDR | -22.16% |
2021 Q4 | 346.05 Billion IDR | 29.66% |
2021 FY | 1228.82 Billion IDR | 46.0% |
2021 Q3 | 266.88 Billion IDR | -10.9% |
2021 Q2 | 299.53 Billion IDR | -5.31% |
2021 Q1 | 316.34 Billion IDR | 0.04% |
2020 FY | 841.67 Billion IDR | 15.27% |
2020 Q4 | 316.22 Billion IDR | 33.6% |
2020 Q1 | 198.77 Billion IDR | 0.21% |
2020 Q2 | 89.97 Billion IDR | -54.74% |
2020 Q3 | 236.7 Billion IDR | 163.08% |
2019 Q4 | 198.35 Billion IDR | 14.92% |
2019 FY | 730.14 Billion IDR | 19.0% |
2019 Q3 | 172.6 Billion IDR | -2.03% |
2019 Q2 | 176.18 Billion IDR | -3.72% |
2019 Q1 | 182.99 Billion IDR | 44.35% |
2018 Q2 | 154.85 Billion IDR | -6.64% |
2018 Q1 | 165.86 Billion IDR | 4.9% |
2018 FY | 613.55 Billion IDR | -9.75% |
2018 Q4 | 126.77 Billion IDR | -23.66% |
2018 Q3 | 166.06 Billion IDR | 7.24% |
2017 Q1 | 184.77 Billion IDR | 11.4% |
2017 Q2 | 167.87 Billion IDR | -9.15% |
2017 FY | 679.8 Billion IDR | -2.25% |
2017 Q4 | 158.11 Billion IDR | -6.46% |
2017 Q3 | 169.03 Billion IDR | 0.69% |
2016 Q1 | 183.92 Billion IDR | 44.28% |
2016 FY | 695.43 Billion IDR | 22.69% |
2016 Q4 | 165.86 Billion IDR | 5.44% |
2016 Q3 | 157.3 Billion IDR | -16.48% |
2016 Q2 | 188.34 Billion IDR | 2.4% |
2015 Q3 | 129.6 Billion IDR | -21.29% |
2015 Q4 | 127.47 Billion IDR | -1.64% |
2015 FY | 566.82 Billion IDR | 9.64% |
2015 Q1 | 145.08 Billion IDR | 17.43% |
2015 Q2 | 164.65 Billion IDR | 13.49% |
2014 Q2 | 141.84 Billion IDR | 12.51% |
2014 Q4 | 123.55 Billion IDR | -1.56% |
2014 FY | 516.99 Billion IDR | 29.69% |
2014 Q3 | 125.51 Billion IDR | -11.52% |
2014 Q1 | 126.08 Billion IDR | 0.0% |
2013 FY | 398.64 Billion IDR | 33.38% |
2012 FY | 298.87 Billion IDR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
PT Bundamedik Tbk | 7.46 Billion IDR | -12178.705% |
PT Metro Healthcare Indonesia Tbk | -110.91 Billion IDR | 925.94% |
PT Medikaloka Hermina Tbk | 437.34 Billion IDR | -109.475% |
PT Murni Sadar Tbk | -12.83 Billion IDR | 7239.544% |
PT Famon Awal Bros Sedaya Tbk | 216.97 Billion IDR | -322.231% |
PT Royal Prima Tbk | -2.74 Billion IDR | 33456.276% |
PT Kedoya Adyaraya Tbk | 25.18 Billion IDR | -3537.051% |
PT Sarana Meditama Metropolitan Tbk | 12.25 Billion IDR | -7377.279% |
PT Siloam International Hospitals Tbk | 1211.28 Billion IDR | 24.367% |
PT Sejahteraraya Anugrahjaya Tbk | -38.49 Billion IDR | 2480.178% |